CIMBERLY BERG-HOOKER: Open Payments
NPI 1497224224 · WESTHOPE, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$431 in 25 payments from 7 companies in 2025. Trend: 2023 $701 · 2024 $524 · 2025 $431
Food & beverage: $431
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $309 |
| Novo Nordisk Inc | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $19 |
| Viatris Specialty LLC | 1 | $18 |
| Galderma Laboratories, L.P. | 1 | $14 |
Products named: VRAYLAR, QULIPTA, Rybelsus, Veozah, TRINTELLIX, ZEPBOUND, YUPELRI.
Industry payments across ND — which companies pay providers there.
